Evidence map›Paper›PMID 12552092›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Coordinate inhibition of expression of several genes for protein subunits of human nuclear RNase P.

Elizaveta Kovrigina, Donna Wesolowski, Sidney Altman

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. The Dynamic Network of RNP RNase P Subunits.International journal of molecular sciences · 2021
    Review
  2. Review
  3. Ribonuclease P.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2011
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Aminoglycoside interactions with RNAs and nucleases.Handbook of experimental pharmacology · 2006
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elizaveta KovriginaDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06520, USA.
Donna Wesolowski
Sidney Altman

Funding

NIGMS NIH HHS GM-194422
6 · The paper itself

Abstract

The deliberate inhibition of expression of one of the protein subunits (Rpp38) of human nuclear RNase P is achievable by using external guide sequence (EGS) technology. Both the protein product and the mRNA are greatly reduced 24 h after transient transfection with a gene coding for an appropriate EGS. Control experiments indicated that four other protein subunits of RNase P and their RNAs are also inhibited with no external manipulation. The remaining RNase P proteins, their mRNAs, and the RNA subunit of RNase P all are unchanged. Several short nucleotide sequences adjacent to the ORFs for the inhibited genes are similar and could be targets for transcriptional repression. The explanation of coordinate inhibition of the expression of the product of one particular gene by the transfection of an EGS (or RNA interference) requires some care in terms of interpreting phenotypic effects because, in our case, several gene products that are not targeted are also inhibited.

Indexed as

Gene Expression Regulation, EnzymologicBase SequenceCell NucleusDNA PrimersEndoribonucleasesFluorescent Antibody Technique, IndirectHeLa CellsHumansImmunoblottingRibonuclease PRNA, CatalyticDNA PrimersEndoribonucleasesRibonuclease PRNA, CatalyticRPP14 protein, human

Identifiers

PMID12552092
PMCPMC149878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.